Lanham O'Dell & Company, Inc. Cocrystal Pharma, Inc. Transaction History

Lanham O'Dell & Company, Inc.

  • $167 Million
  • Q1 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022
SELL
$0.48 - $0.71 $5,760 - $8,520
-12,000 Closed
0 $0
Q4 2021

May 12, 2022
BUY
$0.65 - $1.02 $7,800 - $12,240
12,000 New
12,000 $8,000

About Cocrystal Pharma, Inc.

COCP Quotes by TradingView
  • Ticker COCP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,122,420
  • Market Cap $19.3M
  • Description
  • Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company ...
More about COCP
Track This Portfolio

Track Lanham O'Dell & Company, Inc. Portfolio

Follow Lanham O'Dell & Company, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lanham O'Dell & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Lanham O'Dell & Company, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email